December 25th 2023
Delivering hazardous drugs safely is complex but essential for the welfare of our health care workers and our patients.
The Latest on Acute Lymphocytic Leukemia
View More
A Focus on Acute Myeloid Leukemia
View More
Updates in Myelodysplastic Syndromes
View More
Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?
View More
Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma
View More
Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer
View More
Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Go To PER in Chicago
May 31, 2024 - June 2, 2024
Register Now!
Oncology Consultations®: Next Generation SERDs—Key Data and Practical Takeaways for the Community Physician
View More
Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients With CRPC
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target
View More
Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
Advances In™: Targeting PSMA to Advance Diagnosis And Management Of Patients With Prostate Cancer
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®
View More
Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer
View More
Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed
View More
Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease
View More
B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence
View More
Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer
View More
8th Annual School of Nursing Oncology™
August 10, 2024
Register Now!
7th Annual Live Medical Crossfire®: Hematologic Malignancies
View More
Community Practice Connections™: Integrating BTK Inhibitors Into the CLL/SLL and MCL Treatment Paradigm
View More
Pathology Implications for CEACAM5 as a Therapeutic Target in Advanced NSCLC
View More
2024 Miami International Symposium of Gastrointestinal Oncology (ISGIO)
October 11-12, 2024
Register Now!
Opinion: The Good Nurse Brings Safe Narcotic Handling to the Forefront of Nursing Minds
December 6th 2022Sometimes nurses inappropriately handle high-risk medications. It is important that other nurses, especially those who work in pain management, hold colleagues accountable to promote patient safety.
Fast Facts for the Front Line: Central Line-Associated Bloodstream Infection
August 2nd 2017Preventing central line–associated bloodstream infections is a top priority for healthcare practitioners, and following basic safety protocols, such as handwashing and line flushing, is essential to the effort.
Crafting a Harmonized Approach to Safety
October 26th 2015In her role as division head of Occupational & Environmental Medicine at the University of Maryland, Melissa A. McDiarmid, MD, MPH, spends a lot of her time working with individuals who have been occupationally or environmentally exposed to toxic substances..
As Clinics Await USP 800, Focus Must Remain on Collaboration and Awareness at All Levels
September 16th 2015As the new USP Chapter 800 regulations for the handling of hazardous drugs are being finalized, stakeholders-including oncology nurses-are preparing for a renewed emphasis on the safe preparation and administration of chemotherapy in their daily practice.
Professional Groups Unite to Make Safe Chemo Handling a Priority in Practice
March 24th 2015Big changes are ahead for oncology nurses and other healthcare professionals who prepare and administer hazardous drugs, as new regulations for safe handling are being finalized by the US Pharmacopeial Convention (USP).
Best Practice in Chemotherapy Handling Means Multiple Layers of Precaution
November 18th 2014Several of the nation's leading oncology nurse advocates for raising awareness of the importance of safe handling of chemotherapy drugs gathered recently to discuss some of the current challenges they face in their practices, along with risk reduction strategies that, if adopted, would benefit nurses nationwide.
Multimillion Dollar Research Program Will Study Oncology Nurse Exposure to Hazardous Drugs
September 9th 2014Underscoring the need to raise awareness among oncology nurses of the importance of adhering to safety precautions when administering chemotherapy and other hazardous drugs, the NIOSH has awarded a $2.3 million research grant to identify exposure risks and promote strategies to combat them.
Promoting a Culture of Safe Handling
April 29th 2014April is National Safe Handling Awareness Month, a great time to spotlight the ongoing importance of implementing safe practices when handling chemotherapy and other hazardous drugs in the oncology setting-not only for healthcare practitioners, but for patients and their caregivers, too.